Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
29 Aug 2016 Latest NICE Medtech Innovation Briefings and Technology Appraisal Guidance Recommendations for Cancer Breast cancer - Genitourinary cancers - Haematologic malignancies - Lung and other thoracic tumours - Gastrointestinal cancers
26 Aug 2016 Transparency in Drug Regulation Bioethics, legal and economic issues
24 Aug 2016 Adaptive Pathways: Key Learnings and Next Steps Bioethics, legal and economic issues
23 Aug 2016 Annals of Oncology Press Release: Expecting the Worst Increases Side-Effects in Breast Cancer Patients Receiving Adjuvant Hormone Therapy Breast cancer
22 Aug 2016 Evolving Field of CAR-T-Cell Therapy Haematologic malignancies - Cancer Immunology and Immunotherapy
19 Aug 2016 CAR T Cell Therapy for Diffuse Large B Cell Lymphoma Included in EMA’s PRIority MEdicines Scheme Haematologic malignancies - Cancer Immunology and Immunotherapy
18 Aug 2016 FDA Approves Extended-Release Granisetron Injection for the Prevention of CINV Palliative and supportive care
17 Aug 2016 Palliative Care for Adults: Strong Opioids for Pain Relief Palliative and supportive care
16 Aug 2016 CAR T-cells Targeting the CD4 Protein Granted FDA Orphan Drug Designation Haematologic malignancies - Cancer Immunology and Immunotherapy
12 Aug 2016 In Search of Biomarkers in Onco-Immunology Translational research - Cancer Immunology and Immunotherapy
11 Aug 2016 Developing a Framework of Collaboration Between the EMA and Academia Bioethics, legal and economic issues
09 Aug 2016 FDA Approves Pembrolizumab for Patients with Recurrent or Metastatic HNSCC with Disease Progression on or After Platinum-Containing Chemotherapy Head and neck cancers - Cancer Immunology and Immunotherapy
03 Aug 2016 NICE Issues Technology Appraisal Guidance for Nivolumab in Combination With Ipilimumab for Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy
02 Aug 2016 EMA Recommends Extension of Therapeutic Indications for Ibrutinib Haematologic malignancies - Anticancer agents & Biologic therapy
28 Jul 2016 EMA Recommends Granting a Marketing Authorisation for Pegylated Liposomal Formulation of Irinotecan for Metastatic Pancreatic Adenocarcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy